In vitro interactions of abiraterone, erythromycin, and CYP3A4: implications for drug–drug interactions.Published in:Fundamental & Clinical Pharmacology, 2020, v. 34, n. 1, p. 120, doi. 10.1111/fcp.12497By:Masamrekh, Rami A.;Kuzikov, Alexey V.;Haurychenka, Yaraslau I.;Shcherbakov, Kirill A.;Veselovsky, Alexander V.;Filimonov, Dmitrii A.;Dmitriev, Alexander V.;Zavialova, Maria G.;Gilep, Andrei A.;Shkel, Tatsiana V.;Strushkevich, Natallia V.;Usanov, Sergey A.;Archakov, Alexander I.;Shumyantseva, Victoria V.Publication type:Article